Associations between prescription opioid injection and Hepatitis C virus among young injection drug users

References

• Alter, M.J., Gerety, R.J., Smallwood, L., Sampliner, R.E., Tabor, E., Deinhardt, F. … Matanoski, G.M. (1982). Sporadic non-A, non-B hepatitis: Frequency and epidemiology in an urban U.S. population. The Journal of Infectious Diseases, 145, 886–893
   PubMed Web of Science ®Google Scholar
• Barros, A.J., & Hirakata, V.N. (2003). Alternatives for logistic regression in cross-sectional studies: An empirical comparisson of models that directly estimate the prevalence ratio. BMC Medical Research Methodology, 3, 21
   PubMedGoogle Scholar
• Bell, J., Batey, R.G., Farrell, G.C., Crewe, E.B., Cunningham, A.L., & Byth, K. (1990). Hepatitis C virus in intravenous drug users. The Medical Journal of Australia, 153, 274–276
   PubMed Web of Science ®Google Scholar
• Biernacki, P., & Waldorf, D. (1981). Snowball sampling: Problems, techniques and chain-referral sampling. Sociological Methods and Research, 10, 141–163
   Web of Science ®Google Scholar
• Black, R.A., Trudeau, K.J., Cassidy, T.A., Budman, S.H., & Butler, S.F. (2013). Associations between public health indicators and injecting prescription opioids by prescription opioid abusers in substance abuse treatment. Journal of Opioid Management, 9, 5–17
   PubMedGoogle Scholar
• Bruneau, J., Roy, É., Arruda, N., Zang, G., & Jutras-Aswad, D. (2012). The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users. Addiction, 107, 1318–1327
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2008). Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users–New York, November 2004-April 2007. Morbidity And Mortality Weekly Report, 57, 517–521
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. (2011). Hepatitis C virus infection among adolescents and young adults — Massachusetts, 2002–2009. Morbidity And Mortality Weekly Report, 60, 537–541
   PubMedGoogle Scholar
• Clatts, M., Colon-Lopez, V., Giang le, M., & Goldsamt, L. (2010). Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. Journal of Urban Health, 87, 278–291
   PubMed Web of Science ®Google Scholar
• Creswell, J.P. (2006). Mixed methods design. Thousand Oaks, CA: Sage
   Google Scholar
• Davis, W.R., & Johnson, B.D. (2008). Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug and Alcohol Dependence, 92, 267–276
   PubMed Web of Science ®Google Scholar
• Day, C., White, B., Thein, H., Doab, A., Dore, G., Bates, A. … Maher, L. (2008). Experience of hepatitis C testing among injecting drug users in Sydney, Australia. AIDS Care, 20, 116–123
   PubMed Web of Science ®Google Scholar
• Firestone, M., & Fischer, B. (2008). A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: Behaviours, preferences and drug availability. Harm Reduction Journal, 5, 30
   PubMed Web of Science ®Google Scholar
• Fischer, B., Patra, J., Cruz, M.F., Gittins, J., & Rehm, J. (2008). Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users. Drug and Alcohol Review, 27, 625–632
   PubMed Web of Science ®Google Scholar
• Garfein, R., & Doherty, M. (1998). Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. JAIDS, 18, 11–19
   Google Scholar
• Garfein, R., Vlahov, D., Galai, N., Doherty, M., & Nelson, K. (1996). Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health, 86, 655–661
   PubMed Web of Science ®Google Scholar
• Hagan, H., Campbell, J., Thiede, H., Strathdee, S., Ouellet, L., Kapadia, F. … Garfein, R.S. (2006). Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Reports, 121, 710–719
   PubMed Web of Science ®Google Scholar
• Hagan, H., Des Jarlais, D., Stern, R., Lelutiu-Weinberger, C., Scheinmann, R., Strauss, S., & Flom, P.L. (2007). HCV synthesis project: Preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy, 18, 341–351
   PubMed Web of Science ®Google Scholar
• Hagan, H., Pouget, E.R., Williams, I.T., Garfein, R.S., Strathdee, S.A., Hudson, S.M. … Ouellet, L.J. (2010). Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. Journal of Infectious Diseaes, 201, 378–385
   PubMed Web of Science ®Google Scholar
• Hahn, J.A., Page-Shafer, K., Lum, P.J., Bourgois, P., Stein, E., Evans, J.L. … Moss, A.R. (2002). Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. Journal of Infectious Diseases, 186, 1558–1564
   PubMed Web of Science ®Google Scholar
• Havens, J.R., Lofwall, M.R., Frost, S.D.W., Oser, C.B., Leukefeld, C.G., & Crosby, R.A. (2013). Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. American Journal of Public Health, 103, e44–e52
   PubMedGoogle Scholar
• Horyniak, D., Dietze, P., Degenhardt, L., Higgs, P., McIlwraith, F., Alati, R. … Burns, L. (2013). The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs. Drug Alcohol Dependence, 132, 541–546
   PubMed Web of Science ®Google Scholar
• Johnson, K., Fibbi, M., Langer, D., Silva, K., & Lankenau, S. (2013). Prescription drug misuse and risk behaviors among young adult IDUs. Journal of Psychoactive Drugs, 45, 112–121
   PubMed Web of Science ®Google Scholar
• Jones, C.M., Mack, K.A., & Paulozzi, L.J. (2013). Pharmaceutical overdose deaths, United States, 2010. JAMA, 309, 657–659
   PubMed Web of Science ®Google Scholar
• Kirsh, K., Peppin, J., & Coleman, J. (2012). Characterization of prescription opioid abuse in the United States: Focus on route of administration. Journal of Pain & Palliative Care Pharmacotherapy, 26, 348–361
   PubMedGoogle Scholar
• Klevens, R.M., Hu, D.J., Jiles, R., & Holmberg, S.D. (2012). Evolving epidemiology of hepatitis C virus in the United States. Clinical Infectious Diseases, 55, S3–S9
   PubMed Web of Science ®Google Scholar
• Krieger, N., Williams, D.R., & Moss, N.E. (1997). Measuring social class in US public health research: Concepts, methodologies, and guidelines. Annual Review of Public Health, 18, 341–378
   PubMed Web of Science ®Google Scholar
• Lankenau, S., & Clatts, M. (2005). Patterns of polydrug use among ketamine injectors in New York City. Substance Use & Misuse, 40, 1381–1397
   PubMed Web of Science ®Google Scholar
• Lankenau, S., Schrager, S., Silva, K., Kecojevic, A., Jackson Bloom, J., Wong, C., & Iverson, E. (2012). Prescription and illicit drug use among high-risk young adults in Los Angeles and New York. Journal of Public Health Research, 1, 1–9
   PubMedGoogle Scholar
• Lankenau, S., Teti, M., Silva, K., Jackson Bloom, J., Harocopos, A., & Treese, M. (2012a). Patterns of prescription drug misuse among young injection drug users. Journal of Urban Health, 89, 1004–1016
   PubMed Web of Science ®Google Scholar
• Lankenau, S., Teti, M., Silva, K., Jackson Bloom, J., Harocopos, A., & Treese, M. (2012b). Initiation into prescription opioid misuse amongst young injection drug users. International Journal on Drug Policy, 23, 37–44
   PubMed Web of Science ®Google Scholar
• Lankenau, S., Wagner, K., Jackson Bloom, J., Sanders, B., Hathazi, D., & Shin, C. (2010). The first injection event: Differences among heroin, methamphetamine, cocaine, and ketamine initiates. Journal of Drug Issues, 40, 241–262
   PubMed Web of Science ®Google Scholar
• Ly, K.N., Xing, J., Klevens, R.M., Jiles, R.B., & Ward, J.W. (2012). The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Annals of Internal Medicine, 156, 271–278
   PubMed Web of Science ®Google Scholar
• Mickey, J., & Greenland, S. (1989). A study of the impact of confounder-selection criteria on effect estimation. American Journal of Epidemiology, 129, 125–137
   PubMed Web of Science ®Google Scholar
• Miller, C.L., Johnston, C., Spittal, P.M., Li, K., Laliberté, N., Montaner, J.S.G., & Schechter, M.T. (2002). Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology, 36, 737–742
   PubMed Web of Science ®Google Scholar
• O’Keefe, D., Aitken, C., Higgs, P., & Dietz, P. (2013). Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs. Drug and Alcohol Review, 32, 208–210
   PubMed Web of Science ®Google Scholar
• Okie, S. (2010). A flood of opioids, a rising tide of deaths. New England Journal of Medicine, 363, 1981–1985
   PubMed Web of Science ®Google Scholar
• Paulozzi, L. (2012). Prescription drug overdose: A review. Journal of Safety Research, 43, 283–289
   PubMed Web of Science ®Google Scholar
• Roy, E., Arruda, N., & Bourgois, P. (2011). The growing popularity of prescription opioid injection in downtown Montréal: New challenges for harm reduction. Substance Use & Misuse, 46, 1142–1150
   PubMed Web of Science ®Google Scholar
• Roy, E., Arruda, N., Leclerc, P., Haley, N., Bruneau, J., & Boivin, J.F. (2012). Injection of drug residue as a potential risk factor for HCV acquisition among Montréal young injection drug users. Drug and Alcohol Dependence, 126, 246–250
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (2011). Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration
   Google Scholar
• Surratt, H., Kurtz, S.P., & Cicero, T.J. (2011). Alternate routes of administration and risk for HIV among prescription opioid abusers. Journal of Addictive Diseases, 30, 334–341
   PubMed Web of Science ®Google Scholar
• Tabachnick, B.G., & Fidell, L.S. (2006). Using multivariate statistics (5th ed.). Needham Heights, MA: Allyn and Bacon
   Google Scholar
• Thorpe, L.E., Ouellet, L.J., Hershow, R., Bailey, S.L., Williams, I.T., Williamson, J. … Garfein, R.S. (2002). Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology, 155, 645–653
   PubMed Web of Science ®Google Scholar
• U.S. Deparment of Justice. (2008). Appalachia: High intensity drug trafficking area. National Intelligence Drug Center
   Google Scholar
• Valdiserri, R., Khalsa, J., Dan, C., Holmberg, S., Zibbell, J., Holtzman, D. … Compton, W. (2014). Confronting the emerging epidemic of HCV infection among young injection drug users. American Journal of Public Health, 104, 816–821
   PubMed Web of Science ®Google Scholar
• van den Hoek, J.A.H., van Haastrecht, H.J.A., Goudsmit, J., de Wolf, F., & Coutinho, R.A. (1990). Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. Journal of Infectious Diseases, 162, 823–826
   PubMed Web of Science ®Google Scholar
• Watters, J.K., & Biernacki, P. (1989). Targeted sampling: Options for the study of hidden populations. Social Problems, 36, 416–430
   Web of Science ®Google Scholar
• Zhang, J., & Yu, K.F. (1998). What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA, 280, 1690–1691
   PubMed Web of Science ®Google Scholar
• Zou, G. (2004). A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology, 159, 702–706
   PubMed Web of Science ®Google Scholar